Debra Wadford
Biographic Data
| ID | 9069411 |
|---|---|
| NAME | Debra Wadford |
| GIVEN NAMES | Debra |
| FAMILY NAME | Wadford |
| SIGNATURE | WADFORD D |
| AFFILIATIONS | California Department of Public Health |
| ORCID | 0000-0002-8630-427X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Sars-CoV-2 genomic surveillance using rapid point of care Covid-19 antigen tests at public test sites in California
California’s SARS-CoV-2 genomic surveillance program (California COVIDNet) developed whole genomic sequencing (WGS) capability from positive COVID-19 antigen tests to maintain genomic surveillance from public test sites. Over 4-months, COVIDNet sourced specimens from positive COVID-19 antigen tests from 142 California public test sites in 43 counties. Successful WGS was defined as at least 83% reference coverage with a minimum 20x genomic read de…
Implementation of California Covidnet – a multi-sector collaboration for statewide Sars-CoV-2 genomic surveillance
Introduction: The SARS-CoV-2 pandemic represented a formidable scientific and technological challenge to public health due to its rapid spread and evolution. To meet these challenges and to characterize the virus over time, the State of California established the California SARS-CoV-2 Whole Genome Sequencing (WGS) Initiative, or "California COVIDNet". This initiative constituted an unprecedented multi-sector collaborative effort to achieve large-…
Travel history among persons infected with Sars-CoV-2 variants of concern in the United States, December 2020—February 2021
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected internationally. This investigation examined available travel history of coronavirus disease 2019 (COVID-19) cases reported in the U.S. in whom laboratory testing showed one of these initial VOCs. Travel …
No prominent works on this page.
Implementation of California Covidnet – a multi-sector collaboration for statewide Sars-CoV-2 genomic surveillance
Introduction: The SARS-CoV-2 pandemic represented a formidable scientific and technological challenge to public health due to its rapid spread and evolution. To meet these challenges and to characterize the virus over time, the State of California established the California SARS-CoV-2 Whole Genome Sequencing (WGS) Initiative, or "California COVIDNet". This initiative constituted an unprecedented multi-sector collaborative effort to achieve large-…
Travel history among persons infected with Sars-CoV-2 variants of concern in the United States, December 2020—February 2021
The first three SARS-CoV-2 phylogenetic lineages classified as variants of concern (VOCs) in the United States (U.S.) from December 15, 2020 to February 28, 2021, Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1) lineages, were initially detected internationally. This investigation examined available travel history of coronavirus disease 2019 (COVID-19) cases reported in the U.S. in whom laboratory testing showed one of these initial VOCs. Travel …
Sars-CoV-2 genomic surveillance using rapid point of care Covid-19 antigen tests at public test sites in California
California’s SARS-CoV-2 genomic surveillance program (California COVIDNet) developed whole genomic sequencing (WGS) capability from positive COVID-19 antigen tests to maintain genomic surveillance from public test sites. Over 4-months, COVIDNet sourced specimens from positive COVID-19 antigen tests from 142 California public test sites in 43 counties. Successful WGS was defined as at least 83% reference coverage with a minimum 20x genomic read de…
Medicine (3 works) · SARS-CoV-2 and COVID-19 Research (3 works) · SARS-CoV-2 detection and testing (3 works) · Biology (2 works) · Genetics (2 works) · Genome (2 works) · Internal Medicine (2 works) · Public health (2 works) · Public health surveillance (2 works) · Whole genome sequencing (2 works)